- Sheffield scientists create 3D printed parts to kill bacteria
- Propanc Biopharma gets advance overseas finding from BIS Australia
- TenNor recevies FDA ODD for treating prosthetic joint infections
- Bioprocessing Summit Europe Returns with New Analytical and Formulation Sessions
- Calidi Biotherapeutics raises funds from 2 Korean firms
- PhoreMost, Otsuka collaborate for multi drug discovery projects
- Medical Director of Amaris B. Clinic Predicts 2020 Cosmetic Surgery Trend
- Hitachi Chemical inks pact with Ori Biotech
- Eppendorf is proudly sponsoring the 2020 International Freezer Challenge
- Eppendorf SafeCode system enables a safe sample vial tracking
- Eppendorf & Science Prize for Neurobiology 2020 Call for Entries!
- Chi-Med to stop pancreatic cancer trial upon early success
- 3B Scientific to acquire iSimulate
- KT, Samsung Medical Center create 5G-powered smart hospitals
-
World | 12 December 2019 | News
Researchers unfold genetic code that controls cell function and disease
A research team led by Queen’s University Belfast has made a breakthrough discovery around how and why o...Read more
Europe | 05 November 2019 | Influencers
TPP Commits To Transform The Delivery of Health and Care Globally
Nov Special Interview - Malaysia. TPP is a healthcare technology company, dedicated to delivering world...Read more
-
Australia | 22 January 2020 | News
Propanc Biopharma gets advance overseas finding from BIS Australia
Australia based Propanc Biopharma, Inc., a biopharmaceutical company developing new cancer treatments for pati...Read more
-
World | 22 January 2020 | News
Sheffield scientists create 3D printed parts to kill bacteria
Researchers from the University of Sheffield in the UK have, for the first time, manufactured 3D printed parts...Read more
-
Middle East countries | 16 July 2019 | News
Filterlex Medical raises $3M in Series A Financing
Filterlex Medical is a medical device start-up company based in Israel, developing an innovative embolic ...Read more
-
Thailand | 30 July 2019 | News
Thai startups to capture a major chunk of healthcare market
The medical device market in ASEAN is predicted to be worth US$8.5 billion by 2021, and Thai entrepreneurs wan...Read more
ACT TIMELY
In 2019, we saw Asia developing itself into a major hub for medtech and biopharma activities for both local as well multinational companies. Biotech companies in the region entered into partnerships with leading global biopharmaceutical companies on both the R&D and commercial fronts. Now, as we enter into 2020, the industry plans to further rise in the medtech, biopharma and startups space within Asia focusing on applied research, new technologies, affordability and manageability.
